Non-Hodgkin lymphoma and Hodgkin disease: coregistered FDG PET and CT at staging and restaging--do we need contrast-enhanced CT?
about
Multicenter Comparison of Contrast-Enhanced FDG PET/CT and 64-Slice Multi-Detector-Row CT for Initial Staging and Response Evaluation at the End of Treatment in Patients With LymphomaCT diagnosis of 52 patients with lymphoma in abdominal lymph nodesF-18 fluorodeoxyglucose positron emission tomography and/or computed tomography findings of an unusual breast lymphoma case and concurrent cervical cancer: a case reportDiagnostic value of diffusion-weighted magnetic resonance imaging compared with fluorodeoxyglucose positron emission tomography/computed tomography for pancreatic malignancy: a meta-analysis using a hierarchical regression model.Interim FDG-PET Scan in Hodgkin's Lymphoma: Hopes and Caveats18F-FDG PET/CT imaging in oncologyExtranodal lymphoma originating in the gluteal muscle with adjacent bone involvement and mimicking a soft tissue sarcoma.Appropriateness criteria of FDG PET/CT in oncology.PET in lymphoma.Fluorine-18 fluorodeoxyglucose PET-CT for extranodal staging of non-Hodgkin and Hodgkin lymphoma.18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Management of Aggressive Non-Hodgkin's B-Cell LymphomaThe usefulness of (18)F-FDG PET/CT for assessing methotrexate-associated lymphoproliferative disorder (MTX-LPD)Spleen in haematological malignancies: spectrum of imaging findingsPositron emission tomographic scans in lymphoma: convention and controversy.Increased x-ray attenuation in malignant vs. benign mediastinal nodes in an orthotopic model of lung cancerRare case of Primary Pulmonary Extranodal Non-Hodgkin's Lymphoma in a Patient with Sjogren's Syndrome: Role of FDG-PET/CT in the Initial Staging and Evaluating Response to Treatment.PET and PET/CT for response evaluation in lymphoma: current practice and developments.FDG PET and risk-adapted therapy in Hodgkin's and non-Hodgkin's lymphoma.Pigmented villonodular synovitis mimics metastases on fluorine 18 fluorodeoxyglucose position emission tomography-computed tomography.Overview of early response assessment in lymphoma with FDG-PET.PET/CT in oncology: for which tumours is it the reference standard?PET-CT for Evaluation of Spleen and Liver 18F-FDG Diffuse Uptake Without Lymph Node Enlargement in Lymphoma.State-of-the-Art Research on "Lymphomas: Role of Molecular Imaging for Staging, Prognostic Evaluation, and Treatment Response".Evolution of radiation techniques in the treatment of mediastinal lymphoma: from 3D conformal radiotherapy (3DCRT) to intensity-modulated RT (IMRT) using helical tomotherapy (HT): a single-centre experience and review of the literatureRole of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group.Combined PET and low-dose, noncontrast CT scanning obviates the need for additional diagnostic contrast-enhanced CT scans in patients undergoing staging or restaging for lymphoma.FDG-PET imaging in hematological malignanciesWhole-body diffusion-weighted imaging in lymphoma.Magnetic resonance imaging of malignant lymphoma.Impact of FDG-PET/CT in the management of lymphoma.Advances in oncologic imaging: update on 5 common cancers.Current status of PET/CT in the diagnosis and follow up of lymphomas.The impact of systemic chemotherapy on testicular FDG activity in young men with Hodgkin's lymphoma.When should FDG-PET be used in the modern management of lymphoma?Current role of FDG PET/CT in lymphoma.Diagnostic imaging in paraneoplastic autoimmune multiorgan syndrome: retrospective single site study and literature review of 225 patients.Integrated FDG PET/CT: Utility and Applications in Clinical Oncology.Utility of interim and end-of-treatment PET/CT in peripheral T-cell lymphomas: A review of 124 patients.PET-directed therapy in Hodgkin lymphoma: Ready for prime time?PET-CT in Staging, Response Evaluation, and Surveillance of Lymphoma.
P2860
Q30491972-2E5D4F15-7037-471F-8890-219A79EB91DBQ33866763-F5EC10A4-DCD4-4A40-97D0-D54F3EE3CA2DQ34105155-C0E192FC-8B27-4BCC-BB65-D5EBF689DDCEQ34194318-14E0E64D-2596-48A7-A79E-86F1677091D1Q34475763-F78F292B-D48A-481B-8F4D-92E5DDD7D9E7Q35006097-D2004CB5-7D56-4723-85E6-69326F8ECC5EQ35107483-3FABC1C5-5A60-4C5C-8202-136F83EA67BCQ35568776-BF221E53-7A33-49E9-903A-E17D08636982Q35650641-0BAF2879-66DE-41E5-802E-C7B322E2D21BQ35720831-0CDFFCAB-56FD-4F4C-B67F-10A2DCC8FCC3Q35855599-5803CA93-8516-42F3-AD73-EB23701BF4B3Q36104671-105FD29E-C892-4FBE-85FB-F555C942438BQ36325538-35E7449A-0626-4A35-BEB4-0DC4D52FF0C6Q36399538-CEE327FC-816B-47ED-9CC4-FEB11407EC52Q36462717-0B37CC0D-45A4-43A5-99B0-B25E9F221B9EQ36664666-657C3D7E-ABD3-4B13-98D4-51E47012D6D8Q36746441-50F25CA9-CE36-4656-8A65-BA69630720E3Q36838768-8442F1B1-3DB7-4E70-BDED-8741F9492DA4Q36874487-BB1154FE-3705-42F0-9378-DF42BD14E4BDQ36927213-51F64F29-AF33-4EEC-9388-6F9AA29FC212Q36963748-DCE8924F-0FE6-4F4E-8790-8FD5FD14ACA6Q36993224-4B2DDDA0-D646-4DEE-9651-8823A76D11B4Q37144956-59D36591-2E9F-48FF-BDE7-8AB45A6A0A47Q37178817-AB60E25B-53BE-4DD7-AFEC-5B242ED1DF98Q37240835-AC0592D9-945D-48E1-AD8D-C5B9223D525FQ37326204-4FD4CCDA-E487-4E79-AB7D-DB6EACD1CDA7Q37632114-A7FFC32B-D103-42B4-B100-28CB6D9E3DBBQ37794481-4F982AC3-8EB0-4A65-B92C-CF01E4E7B20DQ37865544-E42D9947-2B04-4B8C-BAF0-3E012E0E3880Q37950857-758C5BA1-6815-4115-BA28-5A1423FD714EQ38052458-ABB58C05-58EF-4745-88A8-E40157292F05Q38071295-6CB35ADB-B13B-4100-A43F-9782DB114618Q38079743-5E8CEA7E-A68D-4B37-A7FF-3F69F0544F2DQ38153086-CF5199C9-4991-43F8-BED6-9B2D507DA057Q38187365-C85B52CA-CD10-4709-9D66-981F97BDB46EQ38234742-22ADD525-AE00-4C72-AF50-133EAD672C90Q38260852-3EAFB68E-C842-4A21-989C-A333BCF2EA54Q38552173-6825A50D-490A-46E4-8661-D336BE3B7DC2Q38608555-E8CCAB51-A328-4612-813F-253B2758A3A0Q38794783-9DCF5FBE-38E9-4868-B1FA-C077A941CCBF
P2860
Non-Hodgkin lymphoma and Hodgkin disease: coregistered FDG PET and CT at staging and restaging--do we need contrast-enhanced CT?
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Non-Hodgkin lymphoma and Hodgk ...... we need contrast-enhanced CT?
@en
Non-Hodgkin lymphoma and Hodgk ...... we need contrast-enhanced CT?
@nl
type
label
Non-Hodgkin lymphoma and Hodgk ...... we need contrast-enhanced CT?
@en
Non-Hodgkin lymphoma and Hodgk ...... we need contrast-enhanced CT?
@nl
prefLabel
Non-Hodgkin lymphoma and Hodgk ...... we need contrast-enhanced CT?
@en
Non-Hodgkin lymphoma and Hodgk ...... we need contrast-enhanced CT?
@nl
P2093
P1433
P1476
Non-Hodgkin lymphoma and Hodgk ...... we need contrast-enhanced CT?
@en
P2093
Christian Taverna
Gerhard W Goerres
Gustav K von Schulthess
Katrin D M Stumpe
Thomas F Hany
P304
P356
10.1148/RADIOL.2323030985
P407
P577
2004-07-23T00:00:00Z